AD-2071

N/A

Report date: 2024/10/21 09:23:05

NME

Base Information

Drug NameAD-2071

Drug Alias NameAD-2071

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHMG-CoA reductase inhibitors

TargetsHMG-CoA reductase

Therapy Area/IndicationsHyperlipidemiasHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAddpharma Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAddpharma Inc

Active IndicationsN/A

Inactive IndicationsHyperlipidemiasHypertension

ATC CodeN/A